U.S. Food and Drug Administration • Center for Drug Evaluation and Research
CDER - Center for Drug Evaluation and Research Logo

Drug Information

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

CDER ArchivesSpecific AudiencesCDER CalendarRegulatory InformationDrug InformationAbout CDERSide Navigational Buttons

Office of Generic Drugs ANDAs Tentative Approvals
May 2000
 
1 . 75-396 MIDAZOLAM HYDROCHLORIDE FAULDING PHARMACEUTICAL 5/5/00

INJECTION 1 MG (BASE)/ML 5 CO.

MG (BASE)/ML
2 . 75-672 BISOPROLOL FUMARATE AND PUREPAC PHARMACEUTICAL 5/11/00

HYDROCHLOROTHIAZIDE CO.

TABLETS 2.5 MG/6.25 MG 5

MG/6.25 MG 10 MG/6.25 MG
3 . 75-530 MILRINONE LACTATE ESI LEDERLE 5/18/00

INJECTION 1 MG (BASE)/ML (

SINGLE-DOSE VIALS)
4 . 75-501 ENALAPRIL MALEATE CHELSEA LABORATORIES, INC. 5/19/00

TABLETS, USP 2.5 MG 5 MG 10

MG 20 MG
5 . 75-634 ENALAPRILAT INJECTION 1.25 BEDFORD LABORATORIES 5/25/00

MG/ML (1&2 ML SINGLE-DOSE

VIALS)

 


totop.gif (1525 bytes) Back to Top   Back Back to Approvals

FDA/Center for Drug Evaluation and Research
Last Updated: September 10, 200125 Apr 2006 08:48:47 -0400
Originator: OGD
HTML by  PKS